286 related articles for article (PubMed ID: 16912173)
1. Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo.
Kim KS; Sengupta S; Berk M; Kwak YG; Escobar PF; Belinson J; Mok SC; Xu Y
Cancer Res; 2006 Aug; 66(16):7983-90. PubMed ID: 16912173
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion.
Sengupta S; Kim KS; Berk MP; Oates R; Escobar P; Belinson J; Li W; Lindner DJ; Williams B; Xu Y
Oncogene; 2007 May; 26(20):2894-901. PubMed ID: 17130843
[TBL] [Abstract][Full Text] [Related]
3. Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.
Lee J; Park SY; Lee EK; Park CG; Chung HC; Rha SY; Kim YK; Bae GU; Kim BK; Han JW; Lee HY
Clin Cancer Res; 2006 Nov; 12(21):6351-8. PubMed ID: 17085645
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol.
Park SY; Jeong KJ; Lee J; Yoon DS; Choi WS; Kim YK; Han JW; Kim YM; Kim BK; Lee HY
Cancer Lett; 2007 Dec; 258(1):63-9. PubMed ID: 17919812
[TBL] [Abstract][Full Text] [Related]
5. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.
Yu X; Zhang Y; Chen H
BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells.
Ren J; Xiao YJ; Singh LS; Zhao X; Zhao Z; Feng L; Rose TM; Prestwich GD; Xu Y
Cancer Res; 2006 Mar; 66(6):3006-14. PubMed ID: 16540649
[TBL] [Abstract][Full Text] [Related]
7. A novel laminin-induced LPA autocrine loop in the migration of ovarian cancer cells.
Sengupta S; Xiao YJ; Xu Y
FASEB J; 2003 Aug; 17(11):1570-2. PubMed ID: 12824286
[TBL] [Abstract][Full Text] [Related]
8. Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells.
Ray U; Roy Chowdhury S; Vasudevan M; Bankar K; Roychoudhury S; Roy SS
Mol Oncol; 2017 May; 11(5):491-516. PubMed ID: 28236660
[TBL] [Abstract][Full Text] [Related]
9. LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).
So J; Wang FQ; Navari J; Schreher J; Fishman DA
Gynecol Oncol; 2005 Jun; 97(3):870-8. PubMed ID: 15919106
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway.
Bian D; Su S; Mahanivong C; Cheng RK; Han Q; Pan ZK; Sun P; Huang S
Cancer Res; 2004 Jun; 64(12):4209-17. PubMed ID: 15205333
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice.
Li H; Wang D; Zhang H; Kirmani K; Zhao Z; Steinmetz R; Xu Y
Mol Cancer Ther; 2009 Jun; 8(6):1692-701. PubMed ID: 19509252
[TBL] [Abstract][Full Text] [Related]
12. Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells.
Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Cho M; Suh DS; Yoon MS; Chang CL; Jung JS; Kim JH
Stem Cells; 2008 Mar; 26(3):789-97. PubMed ID: 18065393
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid modulates the association of PTP1B with N-cadherin/catenin complex in SKOV3 ovarian cancer cells.
Huang RY; Wen CC; Liao CK; Wang SH; Chou LY; Wu JC
Cell Biol Int; 2012 Sep; 36(9):833-41. PubMed ID: 22582758
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid in malignant ascites stimulates migration of human mesenchymal stem cells.
Lee MJ; Jeon ES; Lee JS; Cho M; Suh DS; Chang CL; Kim JH
J Cell Biochem; 2008 May; 104(2):499-510. PubMed ID: 18027882
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells.
Symowicz J; Adley BP; Woo MM; Auersperg N; Hudson LG; Stack MS
Cancer Res; 2005 Mar; 65(6):2234-42. PubMed ID: 15781636
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus.
Ha JH; Ward JD; Radhakrishnan R; Jayaraman M; Song YS; Dhanasekaran DN
Oncotarget; 2016 Jun; 7(25):37664-37679. PubMed ID: 27166196
[TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts.
Radhakrishnan R; Ha JH; Jayaraman M; Liu J; Moxley KM; Isidoro C; Sood AK; Song YS; Dhanasekaran DN
Cancer Lett; 2019 Feb; 442():464-474. PubMed ID: 30503552
[TBL] [Abstract][Full Text] [Related]
18. [Lysophosphatidic acid (LPA) stimulates invasion and metastatic colonization of ovarian cancer cells through Rac activation].
Yu X; Zhang Y; Chen H
Zhonghua Zhong Liu Za Zhi; 2015 Feb; 37(2):95-100. PubMed ID: 25975684
[TBL] [Abstract][Full Text] [Related]
19. Activation of AMP-activated protein kinase is essential for lysophosphatidic acid-induced cell migration in ovarian cancer cells.
Kim EK; Park JM; Lim S; Choi JW; Kim HS; Seok H; Seo JK; Oh K; Lee DS; Kim KT; Ryu SH; Suh PG
J Biol Chem; 2011 Jul; 286(27):24036-45. PubMed ID: 21602274
[TBL] [Abstract][Full Text] [Related]
20. Discoidin Domain Receptor 2 Mediates Lysophosphatidic Acid-Induced Ovarian Cancer Aggressiveness.
Jeong BY; Cho KH; Yoon SH; Park CG; Park HW; Lee HY
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
